Physician profile
Amin Alishahi
NPI 1568806107
$9,516.47
in general payments reported to CMS, 2019-2025
58 companies · $1,265 in 2025
The $1,265 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,956 · 2020: $1,349 · 2021: $1,136 · 2022: $1,317 · 2023: $1,102 · 2024: $1,392 · 2025: $1,265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,759.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,044.44 | 2019-2025 | Octrode, Proclaim, Penta |
| Nevro Corp. | $608.04 | 2019-2022 | |
| Ucb, INC. | $602.77 | 2020-2025 | Rystiggo, Briviact, Nayzilam |
| Medtronic USA, INC. | $573.97 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $365.90 | 2019-2025 | Crexont, Rytary |
| Medtronic, INC. | $348.46 | 2022-2023 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Acadia Pharmaceuticals INC | $295.20 | 2021-2025 | Nuplazid |
| Sk Life Science, INC. | $277.24 | 2022-2025 | |
| Allergan, INC. | $249.87 | 2019-2021 | |
| Abbvie INC. | $144.51 | 2021-2025 | Botox |
| Lilly USA, LLC | $134.88 | 2019-2025 | Kisunla |
| Boston Scientific Corporation | $126.16 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Novartis Pharmaceuticals Corporation | $122.32 | 2019-2025 | |
| Neurelis, INC. | $105.34 | 2020-2025 | Valtoco |
| Argenx US, INC. | $100.64 | 2022-2024 | Vyvgart Hytrulo |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amin Alishahi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.